Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Clinical Translation of Organoids and Organs-on-Chips 2022

Peter Ertl's Biography

Peter Ertl, Professor of Lab-on-a-Chip Systems, Vienna University of Technology

Prof. Ertl holds an engineering degree in Biotechnology (University of Life Sciences, BOKU, Austria), a PhD in Chemistry (University of Waterloo, UW, Canada) and received his postdoctoral training as a biophysicist at University of California at Berkeley (UCB, US). Following a position as Director of Product Development at a UW spin-off venture (Canada), Dr. Ertl joint the Biosensor Technology unit at the Austrian Institute of Technology (AIT). During his tenure at the AIT, Dr. Ertl was also granted a Fulbright Visiting Scholarship at UC Berkeley (2012) and conducted visiting scientist positions at Nanyang Technological University, Singapore (2013), the Medical Center of the University of California at San Francisco (2014). In 2016 he was appointed Professor of Lab-on-a-Chip Systems for Bioscience Technologies at the Vienna University of Technology (TUW), where his research focuses on the development of advanced in vitro diagnostic microsystems and organ-on-a-chip systems. Additionally, Dr Ertl held a visiting research appointment at Imperial College London (UK) in 2019 , is speaker of the Austrian Microfluidics Initiative (AMI) and editor of the open access journal Organs-on-a-Chip (Elsevier).

Peter Ertl Image

Improving Model Quality and Reliability by Combining Organoid Technology with Organ-on-a-Chip Systems

Tuesday, 22 March 2022 at 11:30

Add to Calendar ▼2022-03-22 11:30:002022-03-22 12:30:00Europe/LondonImproving Model Quality and Reliability by Combining Organoid Technology with Organ-on-a-Chip SystemsClinical Translation of Organoids and Organs-on-Chips 2022 in

Organoid technology and in particular embryonic stem cell (ESC) models are of great interest in biomedical research because they provide deeper insights into e.g. neurogenesis and early mammalian brain development. Despite their great scientific potential, the reliable establishment of size-controlled spheroids and three-dimensional embryoid bodies remains a major challenge. The current lack of standardization, robustness and comparability is further l limiting a broader application and translation of stem cell technology. To overcome these limitations a microfluidic biochip array was designed and employed to automate cell loading, establish size-controlled organoids and differentiation protocols using murine P19 embryoid bodies.

Add to Calendar ▼2022-03-21 00:00:002022-03-22 00:00:00Europe/LondonClinical Translation of Organoids and Organs-on-Chips 2022Clinical Translation of Organoids and Organs-on-Chips 2022 in